Freya Meds review
Monthly plans cost more than the quarterly figures, and the dose does not change the price.
The verdict
On its monthly plans, Freya Meds charges $297 for compounded semaglutide and $390 for tirzepatide. The lower $250 and $332 figures apply only with quarterly billing. Monthly dose increases are stated as included at no extra cost.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $297/mo
- Dose published
- Yes
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- LegitScript
- Claimed by provider
Freya Meds sells compounded semaglutide and tirzepatide as weekly injections, each on a monthly or a quarterly plan. Every plan bundles the medication with clinician access, monthly group calls and a one-on-one dietitian consultation.
Who writes the prescription, and what do they see?
A U.S.-licensed doctor reviews the intake quiz and confirms the prescription, which the site says happens the same day. It promises the same practitioner from start to finish. It does not name its clinicians or say whether any live visit takes place.
Care runs through unlimited messaging with the clinician and the wider care team. The product pages also list weekly check-ins for monitoring progress and adjusting the dose. Cancellation is stated as available at any time, with no lock-in.
What happens when the dose goes up?
The published starting doses are 0.20 mg weekly for semaglutide and 2 mg weekly for tirzepatide, with maximums of 2.4 mg and 15 mg. The FAQ says monthly dose increases are built into the plan at no extra cost. How each step is decided for an individual patient is not described.
What the price includes
Monthly plans are $297 for semaglutide and $390 for tirzepatide, and quarterly billing lowers them to $250 and $332. Six months on the monthly semaglutide plan total $1,782. The homepage advertises a lower starting figure that neither product page carries or explains.
What it claims, and what it cites
Both lines are compounded preparations. Compounded drugs are not FDA-approved and get no FDA review before a pharmacy dispenses them, and this site does not name its pharmacy.
Where it holds up, and where it does not
- Strength: Dose increases included at no extra cost
- Strength: Starting and maximum doses are published
- Strength: A dietitian session is included
- Strength: The same practitioner throughout
- Limitation: Lower figures need quarterly billing
- Limitation: Homepage figure missing from product pages
- Limitation: Clinicians and pharmacy are not named
What the evidence says about this kind of treatment
The assessment above is about Freya Meds. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader willing to pay quarterly who wants the monthly dose increases priced in from the start.
- Wrong for
- A reader budgeting from the homepage's starting figure, which the product pages do not support.
The evidence behind what Freya Meds prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Freya Meds compares
| Seller | Who it suits | Go |
|---|---|---|
 YourEra | Readers committing six months who have read which figure belongs to which plan | See YourEra → |
 FitFlow | Buyers who read the plan table before the page title and want the whole ladder in one place | See FitFlow → |
| SkyRx | Buyers ready to prepay a year who want the medication, visit and shipping in one figure | See SkyRx → |
More GLP-1 telehealth sellers reviews: Tonik WellnessTransparent MedsTrava HealthTrellis VitalityTrillium MedsTrimi Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- What does a monthly plan cost?
- $297 for semaglutide and $390 for tirzepatide, and quarterly billing lowers those to $250 and $332.
- Does the price rise with the dose?
- No. The FAQ states the cost stays the same whatever dose the clinician sets, including monthly increases.
- What is the starting dose?
- 0.20 mg weekly for semaglutide and 2 mg weekly for tirzepatide, according to the product pages.
- Is Freya Meds expensive compared with other GLP-1 telehealth sellers?
- Freya Meds publishes a starting figure of $297/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Freya Meds above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.